Universal Health Services (UHS) PT Raised to $271 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Universal Health Services (UHS) PT Raised to $227 at Cantor Fitzgerald
October 28, 2024 6:38 AM EDTCantor Fitzgerald analyst Sarah James raised the price target on Universal Health Services (NYSE: UHS) to $227.00 (from $219.00) while maintaining a Neutral rating.
The analyst comments "We are raising our 12-month price target to $227 from $219. Our 7.9x '26E EV/EBITDA reflects... More
Universal Health Services (UHS) PT Lowered to $211 at RBC Capital
October 28, 2024 6:31 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Universal Health Services (NYSE: UHS) to $211.00 (from $222.00) while maintaining a Sector Perform rating.
The analyst comments "UHS stock traded off ~10% Friday on elevated buyside expectations with several investors pointing to softer... More
Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)
October 28, 2024 5:56 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Buy rating and $240.00 price target on Universal Health Services (NYSE: UHS)
The analyst comments "Net-net. While the election may be an overhang over the next couple of weeks, especially given Trumps position on exchange subsidies; ultimately, we dont believe UHS deserves to be down almost 10% today. The 3Q performance and lack of an increase to guidance wasnt enough to support the stock... More
